FAS and cancer: These findings suggest that the promoter polymorphisms of the FAS and FASLG genes may not contribute to the etiology of cancer [58] and mutation of the primary structure of FAS or FASL might be one of the possible mechanisms that disrupt FAS-mediated apoptosis in tumor cells.